Related Experiment Video
Updated: Jul 5, 2026

Evaluation of Host-Pathogen Responses and Vaccine Efficacy in Mice
Published on: February 22, 2019
Effectiveness of an acellular pertussis vaccine in Japanese children during a non-epidemic period: a matched
1Division of Pediatrics, Fukuoka National Hospital, National Hospital Organization, Japan. okadak@mfukuoka2.hosp.go.jp
Insights
Acellular pertussis vaccines (DTaP) significantly reduced pertussis cases in Japan. DTaP vaccination demonstrated high effectiveness, preventing severe coughing episodes during non-epidemic periods.
Area of Science:
- Pediatrics
- Immunology
- Epidemiology
Background:
- Pertussis (whooping cough) incidence declined in Japan post-DTaP vaccine introduction in 1981.
- Systematic evaluation of DTaP vaccine effectiveness during non-epidemic periods was lacking.
Purpose of the Study:
- To evaluate the vaccine effectiveness (VE) of the Kaketsuken DTaP vaccine.
- To assess DTaP vaccine efficacy in Japanese children during a non-epidemic period.
Main Methods:
- Matched case-control study design.
- Utilized data from Basic Resident Registration and Maternal and Child Health Handbooks.
- Included 15 pertussis cases and 59 controls, analyzing DTaP vaccination history.
Main Results:
- VE of 3 or 4 DTaP vaccinations against pertussis was high.
- Effectiveness was 96.9% for cough lasting 7 days, 96.4% for 14 days, and 95.9% for 21 days.
Conclusions:
- DTaP vaccination demonstrated significant effectiveness in preventing pertussis.
- Findings support the continued use of DTaP vaccines for pertussis control in Japan.
Abstract:
The number of pertussis cases in Japan has decreased dramatically following the nationwide use of an acellular pertussis vaccine combined with diphtheria-tetanus toxoids (DTaP vaccines) which began in 1981. However, the effectiveness of the DTaP vaccine has not been systematically evaluated using appropriate epidemiological methods during a non-epidemic period in Japan. We evaluated the vaccine effectiveness (VE) of the Kaketsuken DTaP vaccine which contains two-component pertussis antigens in Japanese children from 1999 to 2001 using a matched case-control design and data from the Basic Resident Registration and Maternal and Child Health Handbooks. The DTaP vaccination history of 15 children with pertussis and 59 controls was obtained. The VE of 3 or 4 pertussis vaccinations compared with non-vaccination (baseline) was 96.9% for coughing attacks that lasted 7 days, 96.4% for those lasting 14 days, and 95.9% for those lasting 21 days. These findings suggest that DTaP vaccination effectively prevented pertussis during a non-epidemic period in Japan.
More Related Videos
09:37Detection of Polyfunctional T Cells in Children Vaccinated with Japanese Encephalitis Vaccine via the Flow Cytometry Technique
Published on: September 23, 2022
06:22Standardization of Transfer across Labs between Flow Cytometers for Detection of Lymphocytes in Japanese Encephalitis Vaccinated Children
Published on: February 10, 2023
Related Concept Videos
Smallpox
Respiratory Syncytial Virus Disease
Vaccinations
Poliomyelitis